MedPath

Retrospective study of Clinical utility(included pain evaluation) by monthly minodronic acid hydrate for Osteoporosis.

Not Applicable
Conditions
Osteoporosis
Registration Number
JPRN-UMIN000009959
Lead Sponsor
Yoshida Orthopedics Clinic
Brief Summary

56 persons who showed four or more VAS scores in 120 persons were examined. About the pain VAS score, it compared before medication, the fall more significant than one week was shown, and it gradually decreased till 24 weeks. The increase in bone mass density till 24 weeks too.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

1.The patient who offered refused. 2.Investigator judged to be unsuitable as an object of this study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ow back pain by VAS-Scale Change of bone turnover markers Change of bone mineral density
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath